|
SAPS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.66133814775094E-16 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
6.608000E-01 |
| Stage1-vs-Stage3 |
5.095900E-03 |
| Stage1-vs-Stage4 |
1.222030E-04 |
| Stage2-vs-Stage3 |
1.205420E-01 |
| Stage2-vs-Stage4 |
4.960600E-03 |
| Stage3-vs-Stage4 |
1.008800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.0604961353522E-11 |
| Normal-vs-Asian |
1.62481139653892E-12 |
| Caucasian-vs-AfricanAmerican |
8.537800E-01 |
| Caucasian-vs-Asian |
1.378840E-01 |
| AfricanAmerican-vs-Asian |
4.816800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.084000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.85049999767983E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.836100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.638430E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.732600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.864400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.455200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.317200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.95009999995433E-06 |
| Classical-VS-Follicular |
7.709800E-01 |
| Classical-VS-Other |
9.386400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
8.48360000000881E-05 |
| Tall-VS-Other |
1.428450E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.776000E-01 |
| Follicular-VS-Normal |
1.64912528077821E-12 |
| Other-VS-Normal |
8.37129999999853E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.101600E-01 |
|
|
